Home » Newsletters » BioWorld Science

BioWorld Science

March 31, 2015

View Archived Issues

Effects of RO-5506284 assessed by longitudinal beta-amyloid PET imaging

Takeda submits Japanese NDA for three-drug packs to eradicate H. pylori

Eklira Genuair approved in Japan for COPD

Duac combination gel approved in Japan for acne vulgaris

Merck & Co. describes novel IRAK-4 inhibitor with efficacy in inflammation

Selective sodium channel blockers identified at Merck & Co.

Boehringer Ingelheim anti-CD37 MAb gains US orphan status for CLL

Sonidegib named US orphan drug for medulloblastoma

Preliminary data presented from phase II GTx-758 study

EMA validates Zinbryta MAA for relapsing forms of MS

STADA and Hetero Labs plan to form joint venture

Roche and Genentech patent JAK inhibitors

Melinta Therapeutics patent new antimicrobials

CHMP recommends approval of empagliflozin/metformin for type 2 diabetes

MirImmune licenses RXi's self-delivering RNAi technology to develop cancer cell therapies

EMA committee hands down positive opinion for Lenvima in differentiated thyroid carcinoma

Aduro and Novartis establish immune-oncology collaboration

Merck Serono and Intrexon to develop CAR-T therapy

BioDelivery Sciences reports data from phase III study of clonidine gel for diabetic neuropathy

DRM-01 significantly improves acne in a phase IIa trial

Dutch Cancer Society awards grant to develop patient tumor organoids to personalize therapy

The development of genome-wide gain-of-function transcriptional activation screening

Trius divulges new gyrase inhibitors

Allergan patents FPR2 modulators

Sichuan Haisco Pharmaceutical patents FFAR1 agonists

rVSV-ZEBOV Ebola vaccine candidate set for Sierra Leone STRIVE trial

FDA approves new tablet formulation of iron chelator deferasirox

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026